[Antihomotoxic therapy in patients with inflammatory and dystrophic salivary gland diseases].

Traumeel S was used as monotherapy for salivary glands inflammatory and dystrophic disorders. The study showed the drug to be especially efficient by exacerbation of the recurrent disease but the results were poor by indolent disease and on the latter stages of dystrophic disorder. Traumel S may be recommended to be used in combined therapy for salivary glands inflammatory and dystrophic disorders treatment.

[Pharmacological and physiological specificities of local anesthesia in dentistry].

Described in the paper are the specificity of local analgesia at the medical dental procedures and the effect produced by local anesthetics and vasoconstrictive agents on the induction of nervous fibers and peripheral blood circulation. The pharmacological-and-physiological mechanisms of local analgesia by a 2% artikain solution (with adrenalin, concentration 1:100,000) and by a 2% mepivakain solution (with adrenalin, concentration 1:100,000) exerted on the pain sensitivity and blood circulation in the tooth pulp are analyzed.

[Results of comparative studies of psychophysiological factors essential for self-evaluation of pain during oral therapeutic interventions].

The efficiency of infiltration, conduction, and intraligamental anesthesia with different anesthetics for oral therapeutic interventions was evaluated in 331 patients without concomitant somatic diseases. The levels of reactivity and personal anxiety, as well as the patient's mood have an essential impact on their own appraisal of the quality of analgesia, which the dentist should bear in mind when planning and carrying out anesthesia. Mean and high levels of anxiety are characterized by decreased subjective confidence in the quality of analgesia and can mislead the dentist, if he/she neglects these characteristics.

[The use of antihomotoxic therapy in dentistry].

Efficacy of traumel C is assessed in patients with various maxillofacial inflammations. Sixty-nine patients with diseases of the buccal mucosa (aphthous stomatitis, herpes labialis, and perlèches), periodontal tissues, and painful syndrome after dental canal filling were treated. Applications of the drug were administered to patients with diseases of the buccal mucosa and slight or medium-severe periodontitis.

[The comparative efficacy of nonsteroidal anti-inflammatory agents in the combined treatment of periodontal diseases].

Nonsteroid anti-inflammatory drugs (NAID) are compared in 120 patients with periodontitis. The results confirmed clinical efficacy of modern NAID in this patient population. The best clinical results were achieved with voltaren.